- Home
- LPBB vs YMAB Comparison
LPBB vs YMAB Comparison
Compare LPBB & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPBB
- YMAB
- Stock Information
- Founded
- LPBB 2024
- YMAB 2015
- Country
- LPBB United States
- YMAB United States
- Employees
- LPBB N/A
- YMAB N/A
- Industry
- LPBB
- YMAB Biotechnology: Pharmaceutical Preparations
- Sector
- LPBB
- YMAB Health Care
- Exchange
- LPBB NYSE
- YMAB Nasdaq
- Market Cap
- LPBB 289.8M
- YMAB 270.5M
- IPO Year
- LPBB 2024
- YMAB 2018
- Fundamental
- Price
- LPBB $10.10
- YMAB $4.88
- Analyst Decision
- LPBB
- YMAB Buy
- Analyst Count
- LPBB 0
- YMAB 11
- Target Price
- LPBB N/A
- YMAB $19.64
- AVG Volume (30 Days)
- LPBB 8.5K
- YMAB 333.1K
- Earning Date
- LPBB 01-01-0001
- YMAB 03-04-2025
- Dividend Yield
- LPBB N/A
- YMAB N/A
- EPS Growth
- LPBB N/A
- YMAB N/A
- EPS
- LPBB N/A
- YMAB N/A
- Revenue
- LPBB N/A
- YMAB $87,685,000.00
- Revenue This Year
- LPBB N/A
- YMAB $20.07
- Revenue Next Year
- LPBB N/A
- YMAB $8.76
- P/E Ratio
- LPBB N/A
- YMAB N/A
- Revenue Growth
- LPBB N/A
- YMAB 3.38
- 52 Week Low
- LPBB $9.97
- YMAB $4.25
- 52 Week High
- LPBB $10.73
- YMAB $17.78
- Technical
- Relative Strength Index (RSI)
- LPBB N/A
- YMAB 40.52
- Support Level
- LPBB N/A
- YMAB $4.45
- Resistance Level
- LPBB N/A
- YMAB $5.03
- Average True Range (ATR)
- LPBB 0.00
- YMAB 0.39
- MACD
- LPBB 0.00
- YMAB 0.02
- Stochastic Oscillator
- LPBB 0.00
- YMAB 48.15
About LPBB LAUNCH TWO ACQUISITION CORP
Launch Two Acquisition Corp is a blank check company.
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.